Source: European Medicines Agency (EU) Revision Year: 2016 Publisher: biolitec Pharma Ltd., Otto-Schott-Str. 15, 07745, Jena, Germany
Foscan 1 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Dark purple solution. |
Each ml contains 1 mg of temoporfin.
Excipients with known effect: Each ml contains 376 mg of ethanol anhydrous and 560 mg of propylene glycol.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Temoporfin |
Temoporfin is a photosensitising agent used in the photodynamic therapy of tumours. |
| List of Excipients |
|---|
|
Ethanol, anhydrous (E1510) |
Type I amber glass vials with a bromobutyl elastomer stopper and aluminium seal containing either 1 ml or 3 ml or 6 ml of solution for injection.
Each pack contains 1 vial and a filter with Luer lock connections for syringe and cannula. Not all pack sizes may be marketed.
biolitec Pharma Ltd., Otto-Schott-Str. 15, 07745, Jena, Germany
EU/1/01/197/003
EU/1/01/197/004
EU/1/01/197/005
Date of first authorisation: 24 October 2001
Date of latest renewal: 22 September 2011
| Drug | Countries | |
|---|---|---|
| FOSCAN | Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
